The Sure Supply Program is designed to provide health systems with reliable access to medications at risk of shortage, offering a six-month safety stock reserve based on each health system’s purchasing commitments, according to a Feb. 6 news release from the company.
In 2023, over 99% of hospital and health system pharmacists reported drug shortages, driving an increase in demand for mitigation solutions. By negotiating long-term agreements with manufacturers to produce additional inventory, Cencora aims to stabilize the supply chain and reduce the strain on hospitals.
The expanded program covers a range of therapeutic areas, including oncology, critical care, cardiovascular and infectious diseases.
